- About Us
- Healthcare Providers
- Calendar Of Events
- Contact Us
Amy L. Doneen, DNP, ARNP is the co-founder of the Bale/Doneen Method and the Heart Attack & Stroke Prevention Center. She is the medical director of the Heart Attack & Stroke Prevention Center in Spokane, Washington. Doneen is also Adjunct Professor at Texas Tech Health Sciences School of Nursing. She is an international speaker on cardiovascular disease prevention and the co-founder and instructor of the Bale/Doneen Method course for the prevention of heart attacks, strokes and diabetes. She is the chair of the Pacific Northwest Preventative Cardiovascular Nurses Association.
Amy Doneen's full biography
Amy Doneen, RN, BSN, MSN, DNP, ARNP is an international leader in preventing heart attacks, stroke, and diabetes. She has a strong focus on women’s heart health utilizing her skills to define risk assessment and treatment. Since 2002, she has given more than 600 presentations to global medical groups, including to the International Atherosclerosis Society, International Symposium on Atherosclerosis, National Lipid Association Symposium, Women’s Heart Symposium, American Heart Association, Berkeley Heart Lab, and Cleveland Heart Lab. She has been interviewed by major radio and TV news shows, including ESPN reporting the screening of coaches, scouts, and former players from the Seattle Seahawks football team for cardiovascular disease, and WBRZ in Baton Rouge. She has also been published in regional, national and Internet publications.
Doneen is owner and medical director of the Heart Attack & Stroke Prevention Center in Spokane, Washington and cofounder of the Bale/Doneen Method for heart attack, stroke, and diabetes prevention. She presents AAFP accredited continuing medical education (CME) Preceptorship courses several times a year in cities across the United States, training health care providers in such advanced CVD detection techniques as genetic testing, state-of-the-art ultrasound measurements of major arteries, high-tech heart scans, personalized treatment strategies and “fire panel” tests for insulin resistance—cornerstones of the patented Bale/Doneen Method.
Passionate about educating fellow providers about how to save lives, Doneen has been described in a magazine profile as a “risk detective” because the Bale/Doneen Method’s mission is to find the root cause for why patients’ arteries become inflamed and could ignite future heart attacks and strokes if the fire isn’t extinguished early enough. She was co-chair of a national continuing medical education (CME) course for doctors on residual lipid risk in CVD, presented in 20 cities in both 2008 and 2009 and participated in a national Grand Round CME course on metabolic syndrome.
Doneen is an adjunct professor at Texas Tech University Health Science Center School of Nursing and has delivered numerous keynote addresses on women’s heart health at major medical conferences. She did general undergraduate studies at Western Washington University and Eastern Washington University, and received her Associate Degree in Nursing (ADN) and Registered Nurse (RN) from Spokane Community College in 1996. After working as an registered nurse for several years, she returned to school and received her Bachelor of Science in Nursing (BSN), Master of Science in Nursing (MSN), Doctor of Nursing Practice (DNP), and Advanced Registered Nurse Practitioner (ARNP) degrees from Gonzaga University, graduating summa cum laude in 2003.
While working on her graduate thesis, she was shocked to discover, through an extensive review of medical literature, how few studies have been done on CVD in women. She also learned that many women at risk for heart attacks and strokes are missed by the current standard of care, with devastating or even fatal consequences. During her graduate studies, she met Dr. Bradley Bale, who had revamped his family medical practice to pioneer state-of-the-art CVD prevention techniques, such as screening patients for early stage vascular disease using electron beam tomography. Doneen created a thesis project using patients in the practice, comparing the widely used Framingham Risk Score, which predicts CVD risk through such factors as age, gender, cholesterol levels, blood pressure, and smoking status, against checking patients’ arteries for calcium deposits--a better method of evaluating future risk for heart attacks and stroke. Out of this collaboration was born the Bale/Doneen Method for prevention of heart attack, stroke, and diabetes.
Doneen is an international board member and consultant to deCODE Genetics and has served on an international advisory board on the utility of carotid intra-medial thickness, an ultrasound test that screens for heart disease by measuring the amount of plaque in neck arteries. She is chair of Pacific Northwest Chapter of the Preventive Cardiovascular Nurses Association, and has served on the steering committee for “Healthy U” at Deaconess Medical Center. She is on the speakers’ bureau of Abbott Pharmaceuticals, Cleveland HeartLab, and Berkeley HeartLab.
She’s a member of the Society of Atherosclerosis, Imaging, Prevention; American Heart Association; American Stroke Association; Coalition for the Diagnosis and Treatment of Peripheral Artery Disease; and National Lipid Association, and others. Doneen has presented her ambulatory research at the International Society of Prediabetes/Metabolic Syndrom in Madrid Spain 2011 and the International Symposium for Atherosclerosis in Rome, Italy in 2006 and in Boston, in 2009. She also presented data at the European Atherosclerotic Society in Helsinki, Finland in 2007 and at National Lipid Association Annual Symposium in New York City, NY, 2011. In 2009 and 2010, Doneen was a member of a 12 person international committee, for the definition and clinical utility of cIMT with the SAIP Society. In 2007, she was a member of a 4 person National Committee for development and allocation of CME Grand Round presentation on metabolic syndrome. Other participation and presentations at major medical conferences are listed in her online CV.
Amy Doneen's CV
Amy L. Doneen, RN, BSN, MSN, DNP, A.R.N.P
Medical Director of the Heart Attack & Stroke Prevention Center
Adjunct Professor Texas Tech Health Science School of Nursing
Heart Attack & Stroke Prevention Center
507 S. Washington #170
Spokane, WA. 99204
Office: (509) 747-8000
Cell: (509) 953-3377
Honors and recognition:
2008-current: Adjunct Professor at Texas Tech Health Sciences School of Nursing, Lubbock, TX
2006-current: Owner and Medical Director of the Heart Attack & Stroke Prevention Center, Spokane, Washington
1999-current: Co-founder, The Heart Attack Prevention Clinic, partnership with Dr. Bradley Bale, Spokane, Washington
1. Jan. '99 - May '03 Gonzaga University: BSN/MSN/ARNP
2. Sept. '92 - June '94 Spokane Community College: ADN - RN
3. Sept. '90 - June '91 Eastern Washington University General Studies
4. Sept. '88 - June '90 Western Washington University General Studies
Area of Professional Focus: My clinical expertise focuses around advanced cardiovascular risk assessment and comprehensive, global preventive treatment for atherosclerosis, encompassing myocardial infarction prevention and ischemic stroke prevention and diabetes prevention in the primary and secondary population. My risk assessment includes, but is not limited to: Lipid testing, inflammatory marker identification, subparticle measurements, nutrigenomics, genetic risk identification, IMT (Intima Media Thickness Testing), ABI, AAA screening, and Coronary CT for structural assessment, along with identification and treatment of insulin resistance and metabolic syndrome. I take a focused interest in coronary heart disease and women. I am committed to educating the public about heart attack prevention and share my knowledge with other providers to make an international impact on changing the paradigm of treatment to a model of evidenced-based/outcome-based prevention.
Bale/Doneen Method for the Prevention of Heart Attack & Stroke Prevention – 6 features.
1. Patient education – creating partnerships in care between the clinician and the patient
2. Identifying atherosclerosis and monitoring the atherosclerotic process
3. Assessing for inflammation in the endothelium and intima of the arteries
4. Uncovering the root causes – Identifying and treating the core reason for disease development
5. Setting optimal goals of therapy as opposed to the standard of care
6. Individualizing care – using genetics to treat each patient as a unique individual
Professional Speaking opportunities: